Trial Profile

A phase 1 dose escalation clinical study of GCC19CART in patients with relapsed or refractory metastatic colorectal cancer

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 24 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ICTCAR CRC (Primary)
Indications Colorectal cancer
Focus Adverse reactions; Therapeutic Use

Most Recent Events

19 Sep 2024 According to an Innovative Cellular Therapeutics media release, results of the groundbreaking study on GCC19CARTTM therapy has been published in JAMA Oncology on September 19, 2024.
19 Sep 2024 Results published in the Innovative Cellular Therapeutics Media Release.
31 Oct 2023 According to an Innovative Cellular Therapeutics media release, the Company presented updated data at European Society for Medical Oncology (ESMO) Congress 2023 in Madrid, Spain from October 20th to 24.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com